Dr. Wang Zhaoyuan added that in practice, many symptoms caused by the recurrence of colorectal cancer occur before the CEA value increases, and only 25% of patients with recurrence will have an increase in CEA value, which means that three-quarters of colorectal cancer patients are at risk of recurrence without knowing it, indicating that the upgrade of the basic equipment for postoperative follow-up is imminent.
The new generation of detection tool DR70 can detect cancer cells at the early stage of growth, effectively filling the gap of insensitive early CEA, and can help medical teams obtain more accurate recurrence detection and valuable numerical judgment.
